Innovative Trial Design

Support CTNs to transition from the use of conventional trial designs to the use of innovative trial designs where appropriate.

  • Facilitate the availability, dissemination, uptake, and evaluation of innovative methods of trial design
  • Influence policy and promote the development of shared infrastructure that can support innovative trial design

Recent group activities:

  • Most of the outputs for this group are academic and educational events. In early 2019 this reference group held a number of events as part of the ACTA ‘Summer School’ and also hosted a number of webinars as part of ‘Webinar Wednesday’
  • Summer School events:
    • Introduction to Innovative Trial Designs, one day seminar (SYD)
    • Innovative Trial Design Clinic, half-day (SYD)
    • Adaptive clinical trial designs: theory and hands-on skills development, two-day workshop (SYD, MEL, BNE)
  • Webinars include:
    • Studies Within A Trial (SWAT)
    • Hackathon of trial designs
    • FDA guidance for novel trials (Scott Berry)

Group Leadership

  • Prof Andrew Forbes
  • Prof Stephane Heritier
  • Prof Katherine Lee
  • Dr Annie Solterbeck
  • Prof Steve Webb

Members

  • Prof Meera Agar
  • Dr Emily Atkins
  • Ms Sabine Braat
  • Prof Allen Cheng
  • Prof Leonid Churilov
  • Prof Philip Clarke
  • A/Prof Anne Cust
  • Prof Andrew Davidson
  • Prof Val Gebski
  • Ms Elizabeth Griffith
  • Dr Shariful Islam
  • Prof Meg Jardine
  • Ms Annette Jones
  • Dr Julie Marsh
  • Dr Colin McArthur
  • Ms Elaine Pascoe
  • Dr Mark Polizzotto
  • Dr Merran Smith
  • A/Prof Steven Tong
  • A/Prof Andrew Udy
  • Dr Rob Weinkove

Board Sponsors

  • Prof Chris Reid
  • Prof Rachael Morton

Latest Resources

Latest Events